NERD: an umbrella term including heterogeneous subpopulations (Q38092939)

28 August 2017

NERD: an umbrella term including heterogeneous subpopulations (English)

1 reference

28 August 2017

Edoardo Savarino

1

1 reference

28 August 2017

Patrizia Zentilin

series ordinal

2

1 reference

28 August 2017

Vincenzo Savarino

series ordinal

3

1 reference

28 August 2017

language of work or name

English

0 references

publication date

26 March 2013

1 reference

Nature Reviews Gastroenterology & Hepatology

28 August 2017

1 reference

28 August 2017

10

1 reference

28 August 2017

6

1 reference

28 August 2017

371-380

1 reference

https://scigraph.springernature.com/pub.10.1038/nrgastro.2013.50

28 August 2017

0 references

cites work

Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota.

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

Epidemiology of gastro-oesophageal reflux disease: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

Diagnosis and management of non-erosive reflux disease--the Vevey NERD Consensus Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

Gastro-oesophageal reflux symptoms, oesophagitis and Barrett's oesophagus in the general population: the Loiano-Monghidoro study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

The impact of pre-endoscopy proton pump inhibitor use on the classification of non-erosive reflux disease and erosive oesophagitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

Natural history of gastro-oesophageal reflux disease without oesophagitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

Prospective follow-up data from the ProGERD study suggest that GERD is not a categorial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

Predictive factors of the long term outcome in gastro-oesophageal reflux disease: six year follow up of 107 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

Systematic review: does gastro-oesophageal reflux disease progress?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

Reversibility of GERD ultrastructural alterations and relief of symptoms after omeprazole treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

Short-term treatment with proton-pump inhibitors as a test for gastroesophageal reflux disease: a meta-analysis of diagnostic test characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

Accuracy of the diagnosis of GORD by questionnaire, physicians and a trial of proton pump inhibitor treatment: the Diamond Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

Limited ability of the proton-pump inhibitor test to identify patients with gastroesophageal reflux disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

The patient with GORD and chronically recurrent problems

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

Use and utility of the Bravo pH capsule

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

Gastro-oesophageal reflux monitoring: review and consensus report on detection and definitions of acid, non-acid, and gas reflux

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

Combined multichannel intraluminal impedance and pH-metry: a novel technique to improve detection of gastro-oesophageal reflux literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

Twenty-four hour ambulatory simultaneous impedance and pH monitoring: a multicenter report of normal values from 60 healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

Reflux monitoring: current status

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

21 January 2018

Esophageal disorders.

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

Different patterns of oesophageal acid exposure distinguish complicated reflux disease from either erosive reflux oesophagitis or non-erosive reflux disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

Nonerosive Reflux Disease (NERD) - An Update

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

Circadian pattern of intragastric acidity in patients with non-erosive reflux disease (NERD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

The extent of oesophageal acid exposure overlap among the different gastro-oesophageal reflux disease groups.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

Erosive esophagitis and nonerosive reflux disease (NERD): comparison of epidemiologic, physiologic, and therapeutic characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

Combined multichannel intraluminal impedance and manometry testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

Functional heartburn and non-erosive reflux disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

Functional heartburn: definition and management strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

Functional heartburn has more in common with functional dyspepsia than with non-erosive reflux disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

Prevalence and risk factors for overlaps between gastroesophageal reflux disease, dyspepsia, and irritable bowel syndrome: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

Overlap of gastro-oesophageal reflux disease and irritable bowel syndrome: prevalence and risk factors in the general population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

The pathogenesis of heartburn in nonerosive reflux disease: a unifying hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

Dilated intercellular spaces of esophageal epithelium in nonerosive reflux disease patients with physiological esophageal acid exposure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

Esophageal dilated intercellular spaces (DIS) and nonerosive reflux disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

Reassessment of the diagnostic value of histology in patients with GERD, using multiple biopsy sites and an appropriate control group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

Cell proliferation of squamous epithelium in gastro-oesophageal reflux disease: correlations with clinical, endoscopic and morphological data.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

Omeprazole 10 milligrams once daily, omeprazole 20 milligrams once daily, or ranitidine 150 milligrams twice daily, evaluated as initial therapy for the relief of symptoms of gastro-oesophageal reflux disease in general practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

Mechanisms of reflux perception in gastroesophageal reflux disease: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

Short exposure of oesophageal mucosa to bile acids, both in acidic and weakly acidic conditions, can impair mucosal integrity and provoke dilated intercellular spaces

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

Microscopic esophagitis in gastro-esophageal reflux disease: individual lesions, biopsy sampling, and clinical correlations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

Simultaneous intraesophageal impedance and pH measurement of acid and nonacid gastroesophageal reflux: effect of omeprazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

Long-term outcome of microscopic esophagitis in chronic GERD patients treated with esomeprazole or laparoscopic antireflux surgery in the LOTUS trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

Laparoscopic antireflux surgery vs esomeprazole treatment for chronic GERD: the LOTUS randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

Functional heartburn: the stimulus, the pain, and the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

21 January 2018

Mechanisms of heartburn

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

The effect of auditory stress on perception of intraesophageal acid in patients with gastroesophageal reflux disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

Visceral hypersensitivity in non-erosive reflux disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

Capsaicin receptor (TRPV1) and non-erosive reflux disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

Increased TRPV1 gene expression in esophageal mucosa of patients with non-erosive and erosive reflux disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

Different contributions of ASIC channels 1a, 2, and 3 in gastrointestinal mechanosensory function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

Proinflammatory cytokines alter/reduce esophageal circular muscle contraction in experimental cat esophagitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

Viewpoints on Acid-induced inflammatory mediators in esophageal mucosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

Perception of gastro-oesophageal reflux.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

Characteristics of symptomatic reflux episodes on Acid suppressive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

Weakly acidic reflux in patients with chronic unexplained cough during 24 hour pressure, pH, and impedance monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

Nonacid reflux in patients with chronic cough on acid-suppressive therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

How many cases of laryngopharyngeal reflux suspected by laryngoscopy are gastroesophageal reflux disease-related?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

Gastroesophageal reflux and pulmonary fibrosis in scleroderma: a study using pH-impedance monitoring.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

Lowered oesophageal sensory thresholds in patients with symptomatic but not excess gastro-oesophageal reflux: evidence for a spectrum of visceral sensitivity in GORD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

Rabeprazole in nonerosive gastroesophageal reflux disease: a randomized placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

Proton pump inhibitors in GORD An overview of their pharmacology, efficacy and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

Effectiveness of proton pump inhibitors in nonerosive reflux disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

Poor effectiveness of proton pump inhibitors in non-erosive reflux disease: the truth in the end!

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

PPI therapy is equally effective in well-defined non-erosive reflux disease and in reflux esophagitis: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

Review article: alginate-raft formulations in the treatment of heartburn and acid reflux

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

A comparison between sodium alginate and magaldrate anhydrous in the treatment of patients with gastroesophageal reflux symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

Alginate controls heartburn in patients with erosive and nonerosive reflux disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

An evaluation of the antireflux properties of sodium alginate by means of combined multichannel intraluminal impedance and pH-metry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

Esomeprazole 20 mg maintains symptom control in endoscopy-negative gastro-oesophageal reflux disease: a controlled trial of 'on-demand' therapy for 6 months

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

Esomeprazole 20 mg on-demand is more acceptable to patients than continuous lansoprazole 15 mg in the long-term maintenance of endoscopy-negative gastro-oesophageal reflux patients: the COMMAND Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

On-demand therapy for gastroesophageal reflux disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

Combined multichannel intraluminal impedance-pH monitoring to select patients with persistent gastro-oesophageal reflux for laparoscopic Nissen fundoplication

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

Oesophageal acid hypersensitivity is not a contraindication to Nissen fundoplication

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

Subjective and objective data on esophageal manometry and impedance pH monitoring 1 year after endoscopic full-thickness plication for the treatment of GERD by using multiple plication implants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

Baclofen decreases acid and non-acid post-prandial gastro-oesophageal reflux measured by combined multichannel intraluminal impedance and pH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

Psychopharmacologic and behavioral treatments for functional gastrointestinal disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

Efficacy of venlafaxine for symptomatic relief in young adult patients with functional chest pain: a randomized, double-blind, placebo-controlled, crossover trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

Long-term outcome from tricyclic antidepressant treatment of functional chest pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

Normal values and day-to-day variability of 24-h ambulatory oesophageal impedance-pH monitoring in a Belgian-French cohort of healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

Esophageal pH-impedance monitoring and symptom analysis in GERD: a study in patients off and on therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

Intercellular space diameters of the oesophageal epithelium in NERD patients: Head to head comparison between light and electron microscopy analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

Presence of gas in the refluxate enhances reflux perception in non-erosive patients with physiological acid exposure of the oesophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

A comparison of five maintenance therapies for reflux esophagitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

High prevalence of gastroesophageal reflux symptoms and esophagitis with or without symptoms in the general adult Swedish population: a Kalixanda study report

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

An evidence-based appraisal of reflux disease management--the Genval Workshop Report

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

Non-erosive reflux disease (NERD)--acid reflux and symptom patterns

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

Functional esophageal disorders

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

Normal values of 24-h ambulatory intraluminal impedance combined with pH-metry in subjects eating a Mediterranean diet

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

Relationship between gastro-oesophageal reflux pattern and severity of mucosal damage

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

Reflux patterns in patients with short-segment Barrett's oesophagus: a study using impedance-pH monitoring off and on proton pump inhibitor therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

Characteristics of gastro-esophageal reflux episodes in Barrett’s esophagus, erosive esophagitis and healthy volunteers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

Acid, nonacid, and gas reflux in patients with gastroesophageal reflux disease during ambulatory 24-hour pH-impedance recordings

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

Characteristics of Reflux Episodes and Symptom Association in Patients With Erosive Esophagitis and Nonerosive Reflux Disease: Study Using Combined Impedance–pH Off Therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

Esophageal pH-impedance monitoring in patients with therapy-resistant reflux symptoms: 'on' or 'off' proton pump inhibitor?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

The Role of Nonacid Reflux in NERD: Lessons Learned From Impedance-pH Monitoring in 150 Patients off Therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

Predominant nocturnal acid reflux in patients with Los Angeles grade C and D reflux esophagitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

Comparison of esophageal acid exposure distribution along the esophagus among the different gastroesophageal reflux disease (GERD) groups

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

Pathophysiological characteristics of the various forms of gastro-oesophageal reflux disease. Spectrum disease or distinct phenotypic presentations?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

Oesophageal motility and bolus transit abnormalities increase in parallel with the severity of gastro-oesophageal reflux disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

Impedance-pH reflux patterns can differentiate non-erosive reflux disease from functional heartburn patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

GERD: are functional heartburn and functional dyspepsia one disorder?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

Refractory heartburn: comparison of intercellular space diameter in documented GERD vs. functional heartburn

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

The added value of impedance-pH monitoring to Rome III criteria in distinguishing functional heartburn from non-erosive reflux disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

Acid and weakly acidic solutions impair mucosal integrity of distal exposed and proximal non-exposed human oesophagus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

Regional oesophageal sensitivity to acid and weakly acidic reflux in patients with non-erosive reflux disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

Proton-gated cation channels--neuronal acid sensors in the central and peripheral nervous system.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

Comparison of the different characteristics of sensed reflux events among different heartburn groups

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

Characteristics of gastroesophageal reflux in symptomatic patients with and without excessive esophageal acid exposure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

Gastro-oesophageal reflux and aspiration of gastric contents in adult patients with cystic fibrosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

Quantitative assessment and characterization of visceral hyperalgesia evoked by esophageal balloon distention and acid perfusion in patients with functional heartburn, nonerosive reflux disease, and erosive esophagitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

Sustained esophageal contraction: a motor correlate of heartburn symptom

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

It is time to plan clinical trials on true NERD patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

Selective serotonin reuptake inhibitors for the treatment of hypersensitive esophagus: a randomized, double-blind, placebo-controlled study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

Reflux parameters as modified by laparoscopic fundoplication in 40 patients with heartburn/regurgitation persisting despite PPI therapy: a study using impedance-pH monitoring

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

Effects of anti-reflux surgery on weakly acidic reflux and belching

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

Mechanisms of acid, weakly acidic and gas reflux after anti-reflux surgery

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

Randomized trial of sertraline in patients with unexplained chest pain of noncardiac origin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.50

Barrett's esophagus: prevalence and size of hiatal hernia

31 March 2020

1 reference

12 December 2020

Use of pH-impedance testing to evaluate patients with suspected extraesophageal manifestations of gastroesophageal reflux disease

1 reference

12 December 2020

Gastro-oesophageal reflux disease in primary care: an international study of different treatment strategies with omeprazole. International GORD Study Group

1 reference

12 December 2020

Microscopic esophageal mucosal injury in nonerosive reflux disease

1 reference

12 December 2020

Microscopic esophagitis distinguishes patients with non-erosive reflux disease from those with functional heartburn.

1 reference

12 December 2020

In vivo studies on the neutralizing effect of antacids using the Heidelberg capsule

1 reference

12 December 2020

Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.

1 reference

12 December 2020

A critical analysis, with appropriate controls, of gastric acid and pepsin secretion in clinical esophagitis.

1 reference

12 December 2020

Functional heartburn: clinical characteristics and outcome.

1 reference

12 December 2020

Gastroesophageal reflux disease--should we adopt a new conceptual framework?

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRGASTRO.2013.50

1 reference

Dimensions Publication ID

28 August 2017

0 references

1 reference